| Pharmaceutical active ingredients: |
| Isosorbide Mononitrate |
| Available forms, composition and doses of Pentacard: |
| N / A |
| Pentacard medical category: |
| Human:Anti-anginal drugsNitrates and nitrites |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA14 - Isosorbide Mononitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Altana PharmaPacific Healthcare |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Penta 500 | Lysine Hydrochloride; Vitamin B | Unam Corporation; Far East Drug |
| Pentabil | Fenipentol | Officina Farmaceutica Fiorentina Istituto Biochimico |
| Penta-Bromazepam | Bromazepam | Pentapharm |
| Pentabufen | Caffeine; Codeine Phosphate; Ibuprofen; Metamizole Sodium; Phenobarbital | Moscow Pharmaceutical Factory |
| Pentac | Ranitidine | P.C. India Pharma |
| Pentacarinat | Pentamidine Isethionate | Sanofi-Aventis; Armour Pharmaceutical; Gerot Pharmazeutika; GlaxoSmithKline; IDS Group; JHC Healthcare; ZLB Behring |
| Pentacarinate | Pentamidine Isethionate | Sanofi-Aventis; Institute of Pharmaceutical Research and Technology |
| Pentacef | Ceftazidime (Arginine Formulation) | GlaxoSmithKline |
| Pentacel | Bordetella Pertussis inactivated; Filamentous Haemagglutinin; Fimbriae; Haemophilus Influenzae Type B-PRP; Pertactin; Pertussis Toxoid; Poliomyelitis (D.C.O.) Type 1 Mahoney Vaccine inactivated; Poliomyelitis (D.C.O.) Type 2 M.E.F.1 Vaccine inactivated; Poliomyelitis (D.C.O.) Type 3 Saukett Vaccine inactivated; Tetanus Protein; Tetanus Toxoid | Sanofi-Aventis |
| Penta-Cephalexin | Cephalexin Monohydrate | Pentapharm |